
BlackRock Health Sciences Trust (BME) Financial Statements
Price: $36.0874
Market Cap: $478.36M
Avg Volume: 43.23K
Market Cap: $478.36M
Avg Volume: 43.23K
Country: US
Industry: Asset Management
Sector: Financial Services
Industry: Asset Management
Sector: Financial Services
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of BlackRock Health Sciences Trust.
Income Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
---|---|---|---|---|---|---|
Revenue | $24.07M | $20.41M | $-25.97M | $- | $- | $- |
Cost of Revenue | $- | $-8.46M | $- | $- | $- | $- |
Gross Profit | $24.07M | $28.87M | $-25.97M | $- | $- | $- |
Gross Profit Ratio | 100.00% | 141.47% | 100.00% | 0.00% | 0.00% | 0.00% |
Research and Development Expenses | $- | $- | $- | $- | $- | $- |
General and Administrative Expenses | $355.53K | $299.03K | $362.16K | $- | $- | $- |
Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $355.53K | $299.03K | $362.16K | $- | $- | $- |
Other Expenses | $261.57K | $20.11M | $-26.33M | $- | $- | $- |
Operating Expenses | $617.09K | $20.41M | $-25.97M | $- | $- | $- |
Cost and Expenses | $617.09K | $20.41M | $-25.97M | $- | $- | $- |
Interest Income | $- | $- | $- | $- | $- | $- |
Interest Expense | $78 | $55 | $- | $- | $- | $- |
Depreciation and Amortization | $- | $11.56M | $228.49K | $236.56K | $206.30K | $171.86K |
EBITDA | $- | $20.02M | $- | $- | $- | $- |
EBITDA Ratio | 0.00% | 98.11% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | $23.45M | $8.46M | $- | $- | $- | $- |
Operating Income Ratio | 97.44% | 41.47% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income Expenses Net | $- | $11.55M | $-26.47M | $- | $- | $- |
Income Before Tax | $23.45M | $20.02M | $-26.47M | $- | $- | $- |
Income Before Tax Ratio | 97.44% | 98.07% | 101.93% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | $- | $- | $- | $- | $- | $- |
Net Income | $23.45M | $20.02M | $-26.47M | $- | $- | $- |
Net Income Ratio | 97.44% | 98.07% | 101.93% | 0.00% | 0.00% | 0.00% |
EPS | $1.68 | $1.44 | $-2.10 | $-2.55 | $11.63 | $1.45 |
EPS Diluted | $1.68 | $1.44 | $-2.10 | $-2.55 | $11.63 | $1.45 |
Weighted Average Shares Outstanding | 13.94M | 13.94M | 12.61M | 112.88M | 112.70M | 78.09M |
Weighted Average Shares Outstanding Diluted | 13.94M | 13.94M | 12.61M | 112.88M | 112.70M | 78.09M |
SEC Filing | Source | Source | Source | Source | Source | Source |
Balance Sheet
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
---|---|---|---|---|---|---|
Cash and Cash Equivalents | $71.34K | $534 | $3.12K | $960 | $33.69K | $501.31K |
Short Term Investments | $- | $- | $- | $- | $2.51B | $- |
Cash and Short Term Investments | $71.34K | $534 | $3.12K | $960 | $33.69K | $501.31K |
Net Receivables | $1.20M | $1.58M | $2.37M | $3.18M | $375.66K | $574.41K |
Inventory | $- | $- | $- | $- | $- | $- |
Other Current Assets | $-1.20M | $-1.62M | $-2.37M | $-3.18M | $- | $- |
Total Current Assets | $71.34K | $-37.84K | $3.12K | $960 | $409.35K | $1.08M |
Property Plant Equipment Net | $- | $- | $- | $- | $- | $- |
Goodwill | $- | $- | $- | $- | $- | $- |
Intangible Assets | $- | $- | $- | $- | $- | $- |
Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- |
Long Term Investments | $773.33M | $594.40M | $603.68M | $645.54M | $553.11M | $1.72B |
Tax Assets | $- | $- | $- | $- | $- | $- |
Other Non-Current Assets | $-773.33M | $- | $-603.68M | $-645.54M | $-553.11M | $-1.72B |
Total Non-Current Assets | $774.52M | $594.40M | $606.13M | $648.81M | $-2.51B | $1.72B |
Other Assets | $774.59M | $1.74M | $606.13M | $648.81M | $3.07B | $8.75M |
Total Assets | $774.59M | $596.10M | $606.13M | $648.81M | $554.55M | $1.73B |
Account Payables | $- | $- | $233.20K | $12.48M | $114.21K | $1.52M |
Short Term Debt | $- | $- | $- | $- | $- | $- |
Tax Payables | $- | $- | $- | $- | $- | $- |
Deferred Revenue | $- | $- | $- | $- | $- | $- |
Other Current Liabilities | $- | $- | $-233.20K | $-12.48M | $-114.21K | $-1.52M |
Total Current Liabilities | $- | $- | $- | $- | $-1.17M | $1.52M |
Long Term Debt | $- | $- | $- | $- | $- | $- |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- |
Other Non-Current Liabilities | $- | $- | $- | $- | $- | $- |
Total Non-Current Liabilities | $- | $- | $- | $- | $- | $- |
Other Liabilities | $6.03M | $7.97M | $5.93M | $23.04M | $8.62M | $93.49M |
Total Liabilities | $6.03M | $7.97M | $5.93M | $23.04M | $64.01M | $93.49M |
Preferred Stock | $- | $- | $- | $- | $- | $- |
Common Stock | $942.10M | $417.62M | $424.30M | $390.51M | $339.11M | $1.52B |
Retained Earnings | $-173.53M | $170.52M | $175.90M | $235.27M | $206.83M | $117.28M |
Accumulated Other Comprehensive Income Loss | $- | $- | $- | $- | $- | $- |
Other Total Stockholders Equity | $- | $- | $- | $- | $2.48B | $- |
Total Stockholders Equity | $768.57M | $588.14M | $600.20M | $625.77M | $3.02B | $1.64B |
Total Equity | $768.57M | $588.14M | $600.20M | $625.77M | $3.02B | $1.64B |
Total Liabilities and Stockholders Equity | $774.59M | $596.10M | $606.13M | $648.81M | $554.55M | $1.73B |
Minority Interest | $- | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $774.59M | $596.10M | $606.13M | $648.81M | $554.55M | $1.73B |
Total Investments | $773.33M | $594.40M | $603.68M | $645.54M | $3.07B | $1.72B |
Total Debt | $- | $- | $- | $- | $- | $- |
Net Debt | $-71.34K | $-534 | $-3.12K | $-960 | $-211.70K | $-501.31K |
Cash Flow Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
---|---|---|---|---|---|---|
Net Income | $23.45M | $20.02M | $-26.47M | $59.12M | $79.56M | $113.23M |
Depreciation and Amortization | $- | $- | $- | $- | $- | $- |
Deferred Income Tax | $- | $- | $- | $- | $- | $- |
Stock Based Compensation | $- | $- | $- | $- | $- | $- |
Change in Working Capital | $509.26K | $-765.40K | $325.08K | $246.20K | $-385.09K | $70.10M |
Accounts Receivables | $215.91K | $-17.82K | $-146.89K | $5.45K | $- | $- |
Inventory | $- | $- | $- | $- | $- | $- |
Accounts Payables | $- | $- | $- | $- | $-267.88K | $- |
Other Working Capital | $293.36K | $-747.58K | $471.97K | $240.75K | $-117.21K | $- |
Other Non Cash Items | $41.56M | $12.77M | $25.27M | $-80.92M | $-98.53M | $-1.70B |
Net Cash Provided by Operating Activities | $65.52M | $32.02M | $-874.04K | $-21.56M | $-19.35M | $-1.52B |
Investments in Property Plant and Equipment | $- | $- | $- | $- | $- | $- |
Acquisitions Net | $- | $- | $- | $- | $- | $- |
Purchases of Investments | $- | $- | $- | $- | $- | $- |
Sales Maturities of Investments | $- | $- | $- | $- | $- | $- |
Other Investing Activities | $- | $- | $- | $-35.55K | $-970.25K | $- |
Net Cash Used for Investing Activities | $- | $- | $- | $-35.55K | $-970.25K | $- |
Debt Repayment | $-60.69K | $57.77K | $2.92K | $- | $- | $- |
Common Stock Issued | $- | $3.02M | $33.62M | $50.33M | $45.09M | $- |
Common Stock Repurchased | $-29.53M | $- | $- | $- | $- | $- |
Dividends Paid | $-35.92M | $-35.10M | $-32.73M | $-29.00M | $-25.65M | $- |
Other Financing Activities | $- | $-497 | $-19.93K | $20.43K | $- | $1.52B |
Net Cash Used Provided by Financing Activities | $-65.52M | $-32.02M | $876.17K | $21.34M | $19.44M | $1.52B |
Effect of Forex Changes on Cash | $-7 | $-28 | $32 | $-1 | $- | $19 |
Net Change in Cash | $5.51K | $-2.58K | $2.16K | $-210.74K | $10.18M | $9.15M |
Cash at End of Period | $6.05K | $534 | $3.12K | $960 | $211.70K | $9.25M |
Cash at Beginning of Period | $534 | $3.12K | $960 | $211.70K | $125.20K | $100.00K |
Operating Cash Flow | $65.52M | $32.02M | $-874.04K | $-21.56M | $-19.35M | $-1.52B |
Capital Expenditure | $- | $- | $-1 | $-4 | $- | $- |
Free Cash Flow | $65.52M | $32.02M | $-874.04K | $-21.56M | $-19.35M | $-1.52B |